ED Diabetes Screening and Outpatient Care - Aim 3
Recruiting · NCT05899023 · Interventional (participants receive a specific treatment) · Lead sponsor: NYU Langone Health
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.
Who can take part
Inclusion criteria
- Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
- Residential address in New York City or Long Island
- Primary language is English or Spanish
- Able to provide informed consent
Exclusion criteria
- No prior history of diabetes
- No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)
Where it is running
1 location listed across 1 US state.
- NYU Langone Health - New York, New York, United States